Skip to main content

Nivalon Medical

ApplicationYoungstown, USAFounded 2020· One of 351 Application companies tracked by AMPulse

A medical technology company developing the world's first patient-specific, motion-preserving, metal-free spinal implants using AI-driven design and advanced ceramic 3D printing.

CEO / Founder
Todd Hodrinsky
Team Size
1-10
Stage
Active
Total Funding
$1M
Latest Round
Grant
Key Investors
Youngstown Business Incubator (YBI)

Technology & Products

Key Products

["Patient-Specific Ceramic Spinal Implants","AI-Driven Anatomical Modeling & Design Software","Motion-Preserving Intervertebral Solutions","3D-Printed Bio-inert Ceramic Spacers"]

Technological Advantage

Leverages proprietary AI to translate patient CT/MRI scans into custom geometry and utilizes Lithoz LCM technology to print high-performance ceramics (like Zirconia) that mimic bone density and eliminate the 'stress shielding' effect common in metal implants.

Differentiation

Value Proposition

Eliminates the 'one-size-fits-all' limitation of traditional implants by using AI to match a patient's unique anatomy, restoring natural biomechanics and reducing the risks of metal sensitivity and adjacent segment disease.

How They Differentiate

Nivalon differentiates by offering the first metal-free, motion-preserving spinal implants. Unlike competitors like Carlsmed who use AI for patient-specific titanium implants, Nivalon utilizes AI-driven design paired with Lithography-based Ceramic Manufacturing (LCM) to create zirconia-based implants that mimic bone density and eliminate metal sensitivity.

Market & Competition

Target Customers

Orthopedic surgeons, neurosurgeons, specialized spine centers, and hospitals seeking advanced alternatives to traditional metal fusion hardware.

Industry Verticals

["Medical Devices","Healthcare / Spinal Surgery","Additive Manufacturing (3D Printing)","Biotechnology"]

Competitors

Carlsmed; Medtronic; NuVasive (Globus Medical)

Growth & Milestones

Growth Metrics

Transitioned from R&D to functional prototype production in early 2026; secured key US patent for patient-specific spinal geometry.

Major Milestones

["Secured U.S. Patent US-12011336-B2 for 'Patient-specific spinal implants' in June 2024","Named a finalist and winner at the Youngstown Business Incubator (YBI) Shark Tank in 2025","Produced the world’s first fully patient-specific, motion-preserving, metal-free spinal implant in January 2026"]

Notable Customers

Youngstown Business Incubator (Portfolio Company)

Recent coverage of Nivalon Medical